Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Rising incidence and mortality rate of hepatocellular carcinoma in the USA: A comprehensive analysis

Rising incidence and mortality rate of hepatocellular carcinoma in the USA: A comprehensive analysis

Novel treatment strategy shows promise against common liver cancer in children

Novel treatment strategy shows promise against common liver cancer in children

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Identifying immunotherapy resistance in liver cancer linked to steatotic disease

Identifying immunotherapy resistance in liver cancer linked to steatotic disease

Viscoelasticity emerges as key marker for liver cancer in diabetes

Viscoelasticity emerges as key marker for liver cancer in diabetes

Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

Oncofetal ecosystems linked to recurrence and immunotherapy response in liver cancer

Scientists reveal direct link between mitochondrial DNA mutations and cancer treatment response

Scientists reveal direct link between mitochondrial DNA mutations and cancer treatment response

3D-printed liver model paves way for new MASH treatments

3D-printed liver model paves way for new MASH treatments

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

Study links GLP1 agonists to reduced risk of severe liver disease in diabetic patients

HoloCare launches 3D surgical holograms across the UK and Europe

HoloCare launches 3D surgical holograms across the UK and Europe

RBMX protein emerges as key player in cancer progression and immunotherapy response

RBMX protein emerges as key player in cancer progression and immunotherapy response

Novel blood test shows promise in detecting early-stage cancers with high accuracy

Novel blood test shows promise in detecting early-stage cancers with high accuracy

Risk of gastrointestinal cancers translates to one in 12 people developing, and one in 16 people dying from, gastrointestinal cancers

Risk of gastrointestinal cancers translates to one in 12 people developing, and one in 16 people dying from, gastrointestinal cancers

New imaging technique could transform diagnosis and treatment of steatotic liver disease

New imaging technique could transform diagnosis and treatment of steatotic liver disease

£30M clinical study will enhance the understanding of NASH cirrhosis

£30M clinical study will enhance the understanding of NASH cirrhosis

Revolutionary study reveals Lactobacillus acidophilus could ward off liver cancer linked to fatty liver disease

Revolutionary study reveals Lactobacillus acidophilus could ward off liver cancer linked to fatty liver disease

Inhalable point-of-care urinary diagnostic platform for early lung cancer detection

Inhalable point-of-care urinary diagnostic platform for early lung cancer detection

High-resolution map of the neuroblastoma immune landscape points to new target for immunotherapy

High-resolution map of the neuroblastoma immune landscape points to new target for immunotherapy

AI advances could revolutionize hepatocellular carcinoma diagnosis

AI advances could revolutionize hepatocellular carcinoma diagnosis

Simple mail trick doubles liver cancer screening rates for high-risk patients

Simple mail trick doubles liver cancer screening rates for high-risk patients